⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10779930 | 1.00 | — | — | |
| SCHEMBL25046494 | 0.96 | — | — | |
| SCHEMBL24486015 | 0.84 | — | — | |
| SCHEMBL18792957 | 0.78 | — | — | |
| SCHEMBL23888762 | 0.74 | — | — | |
| Iodide SCHEMBL2320726 | 0.70 | — | — | |
| SCHEMBL869782 | 0.69 | — | — | |
| Bromide SCHEMBL7660742 | 0.69 | — | — | |
| Bromide SCHEMBL6151409 | 0.69 | — | — | |
| Bromide SCHEMBL27475758 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220184150-A1 | THERAPEUTIC MICROBIOTA FOR THE TREATMENT AND/OR PREVENTION OF FOOD ALLERGY | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2022-06-16 | — | — | US | disclosed |
| US-10391131-B2 | Therapeutic microbiota for the treatment and/or prevention of food allergy | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2019-08-27 | — | — | US | disclosed |
| US-10265349-B2 | Therapeutic microbiota for the treatment and/or prevention of food allergy | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2019-04-23 | — | — | US | disclosed |
| US-20180117097-A1 | THERAPEUTIC MICROBIOTA FOR THE TREATMENT AND/OR PREVENTION OF FOOD ALLERGY | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2018-05-03 | — | — | US | disclosed |